CD40LG and hepatocellular carcinoma: However, due to the limited number of samples from patients with HCC available for this study, particularly those from patients in an early cancer stage, further investigation is warranted to confirm the clinical significance of IgM-free AIM as a diagnostic marker for early HCC.